HUT47854A - Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment - Google Patents

Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment

Info

Publication number
HUT47854A
HUT47854A HU884319A HU431988A HUT47854A HU T47854 A HUT47854 A HU T47854A HU 884319 A HU884319 A HU 884319A HU 431988 A HU431988 A HU 431988A HU T47854 A HUT47854 A HU T47854A
Authority
HU
Hungary
Prior art keywords
systemic
release
mediating
protection
materials
Prior art date
Application number
HU884319A
Other languages
English (en)
Hungarian (hu)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of HUT47854A publication Critical patent/HUT47854A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU884319A 1987-08-12 1988-08-11 Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment HUT47854A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (1)

Publication Number Publication Date
HUT47854A true HUT47854A (en) 1989-04-28

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
HU884319A HUT47854A (en) 1987-08-12 1988-08-11 Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment

Country Status (19)

Country Link
EP (1) EP0308066B1 (fr)
JP (1) JPH01131119A (fr)
KR (1) KR0131879B1 (fr)
CN (1) CN1050995C (fr)
AT (1) ATE132041T1 (fr)
AU (3) AU2053588A (fr)
CA (1) CA1327002C (fr)
DE (1) DE3854829T2 (fr)
DK (1) DK449888A (fr)
FI (1) FI883763A7 (fr)
HU (1) HUT47854A (fr)
IE (1) IE72103B1 (fr)
IL (1) IL87413A0 (fr)
NO (1) NO883594L (fr)
NZ (1) NZ225799A (fr)
OA (1) OA08901A (fr)
PT (1) PT88266B (fr)
RU (1) RU1834663C (fr)
ZA (1) ZA885967B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (fr) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnostic des déficiences en RNA double-brin
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
WO1991005560A1 (fr) * 1989-10-11 1991-05-02 Hem Research, Inc. Protection contre un choc posterieur a une blessure a l'aide d'arn bicatenaires
HUT65370A (en) * 1989-10-16 1994-05-02 Hem Res Inc Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
CA2120027A1 (fr) * 1991-09-26 1993-04-01 William A. Carter Methode de neutralisation des effets du il-1 au moyen d'arm bicatenairse
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999049029A1 (fr) 1998-03-20 1999-09-30 Benitec Australia Ltd Controle d'expression genique
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (fr) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
CA2482903A1 (fr) * 2002-04-18 2003-10-23 Lynkeus Biotech Gmbh Moyens et procedes pour l'inhibition specifique de genes dans les cellules et le tissu du systeme nerveux central et/ou de l'oeil
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
WO2004022075A1 (fr) * 2002-09-04 2004-03-18 Novartis Ag Traitement de troubles neurologiques par administration d'arn bicaténaire
EP2134172A4 (fr) * 2007-03-05 2011-06-01 Univ Utah State Agoniste restrictif du récepteur 3 de type toll (tlr3)
CA2745832A1 (fr) 2008-12-04 2010-06-10 Opko Ophthalmics, Llc Compositions et procedes pour l'inhibition selective d'isoformes pro-angiogeniques de vegf
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
ATE132041T1 (de) 1996-01-15
CA1327002C (fr) 1994-02-15
FI883763L (fi) 1989-02-13
NO883594L (no) 1989-02-13
PT88266A (pt) 1989-06-30
EP0308066A2 (fr) 1989-03-22
EP0308066B1 (fr) 1995-12-27
DE3854829T2 (de) 1996-08-14
KR890003402A (ko) 1989-04-14
DK449888A (da) 1989-02-13
IL87413A0 (en) 1989-01-31
DE3854829D1 (de) 1996-02-08
DK449888D0 (da) 1988-08-11
EP0308066A3 (fr) 1991-01-16
FI883763A0 (fi) 1988-08-12
RU1834663C (ru) 1993-08-15
NO883594D0 (no) 1988-08-12
AU2053588A (en) 1989-04-20
PT88266B (pt) 1995-05-04
CN1032740A (zh) 1989-05-10
FI883763A7 (fi) 1989-02-13
JPH01131119A (ja) 1989-05-24
AU1001595A (en) 1995-02-23
ZA885967B (en) 1989-07-26
IE72103B1 (en) 1997-03-12
AU1736792A (en) 1992-07-30
CN1050995C (zh) 2000-04-05
IE882399L (en) 1989-02-12
NZ225799A (en) 1991-04-26
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
HUT47854A (en) Release in biological liquids of materials mediating the protection of host organism by systemic two-stranded rna treatment
BR8104189A (pt) Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao
EP0500893A4 (en) Preservation of blood, tissues and biological fluids
GEP19981482B (en) Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B
WO1995021927A3 (fr) Therapie genique de ciblage
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
PT87997A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia
SE8902624D0 (sv) New pharmaceutical preparations
Vignaux et al. Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts
EP1163912A4 (fr) Therapeutique genique
Wargo Interaction of stress and secondary organisms in decline of forest trees.
Manire et al. The chlamydiae.
SU1727820A1 (ru) Способ стимул ции сперматогенеза у быков
WO1993013204A3 (fr) Stimulant de la division de cellules animales
RU93008264A (ru) Состав для биологической стимуляции и коррекции фенотипа организма
Noto JINBUN RONSO
Kurochkin et al. Properties and the protein composition of lymph and blood in burns
Jia Plasmid fingerprinting technique analysis of Pseudomonas aeruginosa isolated from a burn unit
Chang Human trial for gene therapy
Philpott et al. Evasion of the immune system by tumor viruses
VAISFELD et al. Histamine in biochemistry and physiology(Russian book)
Fedulova et al. Effect on Protococcaceae of some detergents used as oil removers).
NO985306D0 (no) Etenholdige oppl°sninger og anvendelse derav ved terapi- og profylaksemetoder
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.
SU1293954A1 (ru) Способ биологической очистки нефтесодержащих сточных вод

Legal Events

Date Code Title Description
DFC9 Refusal of application